Goldman Sachs’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Sell |
106,409
-2,201
| -2% | -$7.05K | ﹤0.01% | 4459 |
|
|
2025
Q1 | $440K | Sell |
108,610
-12,217
| -10% | -$49.5K | ﹤0.01% | 4325 |
|
|
2024
Q4 | $1.28M | Buy |
120,827
+2,007
| +2% | +$21.3K | ﹤0.01% | 3760 |
|
|
2024
Q3 | $2.93M | Sell |
118,820
-8,682
| -7% | -$214K | ﹤0.01% | 3106 |
|
|
2024
Q2 | $3.6M | Buy |
127,502
+3,293
| +3% | +$92.9K | ﹤0.01% | 2842 |
|
|
2024
Q1 | $5.06M | Buy |
124,209
+8,258
| +7% | +$336K | ﹤0.01% | 2558 |
|
|
2023
Q4 | $1.91M | Buy |
115,951
+46,904
| +68% | +$774K | ﹤0.01% | 3235 |
|
|
2023
Q3 | $2.62M | Sell |
69,047
-3,048
| -4% | -$116K | ﹤0.01% | 2920 |
|
|
2023
Q2 | $3.97M | Buy |
72,095
+3,141
| +5% | +$173K | ﹤0.01% | 2732 |
|
|
2023
Q1 | $2.97M | Sell |
68,954
-11,246
| -14% | -$484K | ﹤0.01% | 2936 |
|
|
2022
Q4 | $3.15M | Sell |
80,200
-1,358
| -2% | -$53.4K | ﹤0.01% | 2966 |
|
|
2022
Q3 | $4.33M | Buy |
81,558
+60,196
| +282% | +$3.2M | ﹤0.01% | 2742 |
|
|
2022
Q2 | $1.4M | Buy |
21,362
+845
| +4% | +$55.5K | ﹤0.01% | 3714 |
|
|
2022
Q1 | $1.51M | Buy |
20,517
+13,418
| +189% | +$985K | ﹤0.01% | 3791 |
|
|
2021
Q4 | $503K | Sell |
7,099
-27,804
| -80% | -$1.97M | ﹤0.01% | 4516 |
|
|
2021
Q3 | $8.75M | Sell |
34,903
-2,959
| -8% | -$742K | ﹤0.01% | 2371 |
|
|
2021
Q2 | $10.2M | Sell |
37,862
-14,574
| -28% | -$3.92M | ﹤0.01% | 2233 |
|
|
2021
Q1 | $14.9M | Buy |
52,436
+35,837
| +216% | +$10.2M | ﹤0.01% | 1891 |
|
|
2020
Q4 | $4.71M | Buy |
16,599
+15,847
| +2,107% | +$4.49M | ﹤0.01% | 2503 |
|
|
2020
Q3 | $232K | Sell |
752
-4,508
| -86% | -$1.39M | ﹤0.01% | 4011 |
|
|
2020
Q2 | $1.11M | Buy |
+5,260
| New | +$1.11M | ﹤0.01% | 3163 |
|